V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180000823 | 180002826 | null | null | null | 2020-07-06 | 2020-07-06 | BORTEZOMIB + THALIDOMIDE | null | null | NB HRNBL-1 ISOTRETINOIN | 100608083 |
| 180001100 | 180002832 | 0 | null | null | null | 2018-01-15 | Trabectedin | null | null | NB HRNBL-1 ISOTRETINOIN | 101382347 |
| 180001169 | 180002834 | null | null | null | 2019-11-02 | 2019-11-02 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | TRIAL UNSPECIFIED | 100209111 |
| 180001219 | 180002837 | null | null | null | null | 2017-01-13 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | NB HRNBL-1 ISOTRETINOIN | 100973705 |
| 180001261 | 180002838 | null | null | null | 2019-04-06 | 2019-05-01 | NB HRNBL-1 TVD | null | null | CAPECITABINE + OXALIPLATIN | 101626773 |
| 180001263 | 180002839 | null | null | null | 2019-07-20 | 2019-07-21 | NB HRNBL-1 COJEC Ind COURSE C | null | null | NB HRNBL-1 COJEC IND COURSE B | 101455646 |
| 180001552 | 180002850 | null | null | null | 2017-11-16 | 2017-11-18 | NB HRNBL-1 Isotretinoin | null | null | PACLITAXEL | 100810603 |
| 180001624 | 180002851 | null | null | null | null | 2019-03-18 | Mitotane 3 - 3.5g | null | null | NB HRNBL-1 ISOTRETINOIN | 100784632 |
| 180001626 | 180002852 | null | null | null | 2020-04-30 | 2020-04-30 | CABOZANTINIB | null | null | VENETOCLAX | 100413368 |
| 180001719 | 180002859 | null | null | null | 2018-07-18 | 2018-09-06 | Enzalutamide | null | null | LENVATINIB | 100088022 |
| 180001871 | 180002864 | null | null | null | null | 2020-03-14 | STREPTOZOCIN | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101409663 |
| 180001997 | 180002867 | null | null | null | 2016-07-22 | 2017-06-30 | null | null | null | CARBOPLATIN | 100154149 |
| 180002097 | 180002871 | null | null | null | null | 2018-12-13 | null | null | null | TRETINOIN | 101750654 |
| 180002148 | 180002874 | null | null | null | null | 2022-04-12 | NB HRNBL-1 Isotretinoin | null | null | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 100524241 |
| 180002166 | 180002875 | null | null | null | null | 2021-05-24 | NB HRNBL-1 Isotretinoin | null | null | CABOZANTINIB | 101434215 |
| 180002283 | 180002877 | null | null | null | null | 2016-03-20 | null | null | null | CAPECITABINE | 101073421 |
| 180002345 | 180002880 | null | null | null | null | 2018-09-22 | WT SIOP 2002 01 post op Carbo, Etop | null | null | CARBOPLATIN + PACLITAXEL | 100289131 |
| 180002455 | 180002884 | null | null | null | 2017-10-26 | 2017-12-11 | Dinutuximab Beta | null | null | VANDETANIB | 101498487 |
| 180002718 | 180002892 | null | null | null | 2020-06-12 | 2021-08-09 | STREPTOZOCIN | null | null | DOXORUBICIN | 100029846 |
| 180002835 | 180002896 | null | null | null | null | 2017-12-09 | BUSULFAN + MELPHALAN | null | null | LENVATINIB | 100474100 |
| 180002878 | 180002897 | null | null | null | 2021-12-11 | 2022-03-15 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100558438 |
| 180002895 | 180002898 | 1.65 | null | null | 2016-04-02 | 2017-03-20 | CABOZANTINIB | null | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101719913 |
| 180003112 | 180002905 | null | null | null | null | 2019-10-06 | NB HRNBL-1 BUMEL MAT | null | null | NB HRNBL-1 ISOTRETINOIN | 100353401 |
| 180003139 | 180002907 | null | null | null | null | 2021-10-05 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 100103682 |
| 180003150 | 180002909 | 1.59 | null | null | 2015-09-21 | 2017-05-05 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | DOCETAXEL | 100759506 |
| 180003271 | 180002917 | null | null | null | null | 2017-09-16 | NB BEACON Dinutuximab, Cyclophosphamide and Topotecan | null | null | CABOZANTINIB | 100935407 |
| 180003423 | 180002921 | null | null | null | null | 2018-09-20 | Liposomal Doxorubicin 40mg/m2 | null | null | ABIRATERONE | 100328266 |
| 180003529 | 180002925 | null | null | null | null | 2022-05-01 | CNS GCT II Non Germin - Std PEI | null | null | NB HRNBL-1 ISOTRETINOIN | 100628486 |
| 180003561 | 180002927 | null | null | null | null | 2019-10-12 | NB Low/Intermed risk guidelines CADO | null | null | TEMOZOLOMIDE | 100243533 |
| 180003615 | 180002933 | null | null | null | 2021-01-20 | 2021-04-28 | GDP | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 101377364 |
| 180003626 | 180002934 | null | null | null | null | 2017-12-29 | NB Rel CCLG guidelines Irin & Temoz | null | null | LENVATINIB | 101401458 |
| 180003675 | 180002938 | null | null | null | null | 2016-10-09 | BUSULFAN + MELPHALAN | null | null | RITUXIMAB | 100388807 |
| 180003693 | 180002939 | null | null | null | 2017-01-15 | 2020-01-27 | Trial Unspecified | null | null | NB HRNBL-1 TVD | 101054188 |
| 180003721 | 180002941 | null | null | null | null | 2021-08-19 | null | null | null | ANTIBODY NBL | 101849273 |
| 180003913 | 180002948 | null | null | null | 2020-07-25 | 2021-04-16 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 100923552 |
| 180003921 | 180002950 | null | null | null | null | 2019-06-24 | Vinorelbine (oral) | null | null | LANREOTIDE | 100667986 |
| 180003947 | 180002953 | null | null | null | null | 2018-12-17 | Cyclophosphamide oral | null | null | CARBOPLATIN | 101532498 |
| 180003990 | 180002955 | null | null | null | 2019-12-29 | 2020-04-23 | CABOZANTINIB | null | null | CARBOPLATIN + PEMETREXED | 101774246 |
| 180004007 | 180002957 | null | null | null | 2018-03-16 | 2018-03-17 | Cyclophosphamide + Topotecan | null | null | DOCETAXEL | 100200062 |
| 180004204 | 180002962 | null | null | null | 2018-08-11 | 2019-02-22 | CNS Medullo HR Cis/Vinc/Cyclo + PBSCR | null | null | NB HRNBL-1 ISOTRETINOIN | 101565071 |
| 180004235 | 180002963 | null | null | null | 2018-03-18 | 2018-03-25 | null | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 100191806 |
| 180004243 | 180002964 | null | null | null | 2018-07-21 | 2019-05-24 | Carboplatin + Pemetrexed | null | null | LENVATINIB | 101309088 |
| 180004329 | 180002969 | null | null | null | null | 2018-02-14 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100901107 |
| 180004347 | 180002972 | null | null | null | null | 2019-06-01 | Carboplatin AUC 2 - 5 | null | null | NB HRNBL-1 ISOTRETINOIN | 100759799 |
| 180004495 | 180002976 | null | null | null | 2013-03-24 | 2013-03-27 | Methotrexate High Dose (3g/m2) | null | null | LENVATINIB | 100318441 |
| 180004507 | 180002977 | null | null | null | null | 2021-07-01 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | CARBOPLATIN + PEMETREXED | 100337265 |
| 180004526 | 180002978 | 0 | null | null | null | 2022-04-19 | CARBOPLATIN + ETOPOSIDE | null | null | NB HRNBL-1 ISOTRETINOIN | 100366085 |
| 180004701 | 180002987 | null | null | null | null | 2017-05-09 | LENVATINIB | 2 | null | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101227165 |
| 180004777 | 180002988 | null | null | null | null | 2020-06-18 | LENVATINIB | null | null | CISPLATIN + ETOPOSIDE | 101052062 |
| 180005092 | 180002997 | null | null | null | 2019-06-09 | 2019-07-03 | CABOZANTINIB | 2 | null | NB HRNBL-1 COJEC IND COURSE B | 100972126 |